9999999997-16-027994.txt : 20161222 9999999997-16-027994.hdr.sgml : 20161222 20161222124539 ACCESSION NUMBER: 9999999997-16-027994 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20161222 DATE AS OF CHANGE: 20161222 20161222 20161222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 162065839 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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
&UP34TZ26YS M=&%N8V5)1#X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(#POJ' M5!:DZ@9A* M8,/&*+W2QAAMK%6V4>U"J<7/JN7QY"B^2BM\2G )E&L)K3#"<#FB_S\Y$OJW M"\2VCO ^%1AB+C&E0*"U4'!CUSA[_.0;Y_(<2PILC%7-^"AP1?+0P-+:I165 M _&^_PHP .J20)$-"F5N9'-TF4@,3 O5'EP92]84F5F+U=; M,2 R(#%=/CYS=')E86T-"FC>8F( B9&KD,,3 R,;4""=R&(U0LBV( 2SUJ! M+ 8&1B#!]!](,#( !!@ ?!8%&PT*96YD